×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RSLS – reshape lifesciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RSLS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/14
04:17 pm
rsls
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
High
Report
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/14
04:05 pm
rsls
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update
Low
Report
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update
11/12
04:05 pm
rsls
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
Medium
Report
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
11/12
08:37 am
rsls
ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX [Yahoo! Finance]
Medium
Report
ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX [Yahoo! Finance]
11/12
08:31 am
rsls
ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX
Medium
Report
ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX
11/11
08:31 am
rsls
ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California’s Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape’s Proprietary Diabetes Bloc-
High
Report
ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California’s Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape’s Proprietary Diabetes Bloc-
9/19
08:31 am
rsls
ReShape Lifesciences Announces 1-for-58 Reverse Stock Split
High
Report
ReShape Lifesciences Announces 1-for-58 Reverse Stock Split
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:32 pm
rsls
Form 8-K ReShape Lifesciences For: Nov 14
High
Report
Form 8-K ReShape Lifesciences For: Nov 14
11/14
04:31 pm
rsls
Form 10-Q ReShape Lifesciences For: Sep 30
High
Report
Form 10-Q ReShape Lifesciences For: Sep 30
10/17
09:16 am
rsls
Form 8-K ReShape Lifesciences For: Oct 16
Medium
Report
Form 8-K ReShape Lifesciences For: Oct 16
9/26
04:45 pm
rsls
Form SC 13G/A ReShape Lifesciences Filed by: Schneid Yair
Low
Report
Form SC 13G/A ReShape Lifesciences Filed by: Schneid Yair
9/24
06:01 am
rsls
Form 8-K ReShape Lifesciences For: Sep 18
High
Report
Form 8-K ReShape Lifesciences For: Sep 18
8/28
04:03 pm
rsls
Form 425 ReShape Lifesciences Filed by: ReShape Lifesciences Inc.
Medium
Report
Form 425 ReShape Lifesciences Filed by: ReShape Lifesciences Inc.
8/28
04:02 pm
rsls
Form 425 ReShape Lifesciences Filed by: ReShape Lifesciences Inc.
Medium
Report
Form 425 ReShape Lifesciences Filed by: ReShape Lifesciences Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/11
ReShape Lifesciences Announces 1-for-120 Reverse Stock Split
56.4%
9/4 Form 4 ReShape Lifesciences For: Aug 30 Filed by: Armistice Capital Master Fund Ltd. 16.7%
6/4 ReShape Lifesciences Strengthens Executive Leadership Team with Appointment of Kevin Condrin as Senior Vice President of Commercial 13.6%
5/20 ReShape Lifesciences to Host First Quarter 2019 Conference Call on May 20, 2019 12.5%
4/17 Form 8-K ReShape Lifesciences For: Apr 12 8.7%
2/4 Form 8-K ReShape Lifesciences For: Feb 01 8.2%
8/15 Form NT 10-Q ReShape Lifesciences For: Jun 30 8.0%
9/30 Form 8-K ReShape Lifesciences For: Sep 23 7.1%
10/30 Form 8-K ReShape Lifesciences For: Oct 30 5.3%
9/30 Form SC 13D/A ReShape Lifesciences Filed by: ARMISTICE CAPITAL, LLC 5.0%
9/4 Form 4 ReShape Lifesciences For: Aug 30 Filed by: Armistice Capital Master Fund Ltd. 16.7%
6/4 ReShape Lifesciences Strengthens Executive Leadership Team with Appointment of Kevin Condrin as Senior Vice President of Commercial 13.6%
5/20 ReShape Lifesciences to Host First Quarter 2019 Conference Call on May 20, 2019 12.5%
4/17 Form 8-K ReShape Lifesciences For: Apr 12 8.7%
2/4 Form 8-K ReShape Lifesciences For: Feb 01 8.2%
8/15 Form NT 10-Q ReShape Lifesciences For: Jun 30 8.0%
9/30 Form 8-K ReShape Lifesciences For: Sep 23 7.1%
10/30 Form 8-K ReShape Lifesciences For: Oct 30 5.3%
9/30 Form SC 13D/A ReShape Lifesciences Filed by: ARMISTICE CAPITAL, LLC 5.0%
TOP News Decliners
12/28
Form 8-K ReShape Lifesciences For: Dec 27
-27.5%
3/29 ReShape Lifesciences Announces $2 Million Convertible Note Financing -27.4%
11/26 ReShape Lifesciences Announces $10 Million Registered Direct Offering -24.8%
11/14 Form 8-K ReShape Lifesciences For: Nov 14 -24.7%
5/16 Form 10-K ReShape Lifesciences For: Dec 31 -17.9%
5/20 Q1/2019 3/31/2019 EPS -0.540 ZacksConsensus N/A ActVsEst N/A - N/A -16.7%
10/18 Form DEF 14A ReShape Lifesciences For: Oct 31 -12.3%
8/9 Form 4 ReShape Lifesciences For: Aug 07 Filed by: Armistice Capital Master Fund Ltd. -11.4%
10/1 Form SC 13G/A ReShape Lifesciences Filed by: BIGGER CAPITAL FUND L P -11.1%
6/20 Form SC 13G ReShape Lifesciences Filed by: BIGGER CAPITAL FUND L P -9.8%
3/29 ReShape Lifesciences Announces $2 Million Convertible Note Financing -27.4%
11/26 ReShape Lifesciences Announces $10 Million Registered Direct Offering -24.8%
11/14 Form 8-K ReShape Lifesciences For: Nov 14 -24.7%
5/16 Form 10-K ReShape Lifesciences For: Dec 31 -17.9%
5/20 Q1/2019 3/31/2019 EPS -0.540 ZacksConsensus N/A ActVsEst N/A - N/A -16.7%
10/18 Form DEF 14A ReShape Lifesciences For: Oct 31 -12.3%
8/9 Form 4 ReShape Lifesciences For: Aug 07 Filed by: Armistice Capital Master Fund Ltd. -11.4%
10/1 Form SC 13G/A ReShape Lifesciences Filed by: BIGGER CAPITAL FUND L P -11.1%
6/20 Form SC 13G ReShape Lifesciences Filed by: BIGGER CAPITAL FUND L P -9.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: